Patient and healthcare professional acceptability of pharmacogenetic screening for DPYD and UGT1A1: A cross sectional survey
Abstract This study explored the acceptability of a novel pharmacist‐led pharmacogenetics (PGx) screening program among patients with cancer and healthcare professionals (HCPs) taking part in a multicenter clinical trial of PGx testing (PACIFIC‐PGx ANZCTR:12621000251820). Medical oncologists, oncolo...
Gardado en:
| Principais autores: | , , , , , , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Wiley
2023-12-01
|
| Series: | Clinical and Translational Science |
| Acceso en liña: | https://doi.org/10.1111/cts.13664 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|